Michigan Medicine extends eligibility for COVID-19 vaccination throughout the system

ANN TREE – Michigan Medicine announced Monday in an email to staff that it has expanded the priority group of COVID-19 phase 1A vaccines after administering more than 11,000 vaccines since Dec. 14.

According to state recommendations, those now eligible for a phase 1A vaccine at the University of Michigan include:

• Anyone who plays a role at Michigan Medicine or the University of Michigan who works in a clinical setting (i.e., hospital, outpatient clinic, home care) and cannot work exclusively remotely can receive a COVID-19 vaccine now as apart from phase 1A.
• Anyone who plays a role at the University of Michigan in a clinical setting and cannot work exclusively remotely can also receive a COVID-19 vaccine now as part of Phase 1A. This includes staff and students working in the following areas: university health services, dentistry, nursing, social work, kinesiology, public health, pharmacy, and others working in a clinical setting.

“There will be enough vaccine for everyone and we look forward to new submissions every week,” the email read.

On Monday at 9 a.m., Michigan Medicine reported the following vaccine data:

• Number of total vaccine doses received by the University of Michigan: 11,950
• Number of vaccines administered in the UM community: 10,900
• Number of vaccines administered in the UM community on Sunday, January 3: 870
• Number of vaccination appointments currently scheduled for Monday, January 4 and Tuesday, January 5: 1,594

With a new vaccine shipment expected Tuesday, Michigan Medicine estimates it will schedule the last current phase 1A group through Jan. 12.

Michigan Medicine administers vaccines seven days a week. Michigan Stadium was inaugurated on Thursday as a new vaccination site, which will play a central role in inoculating tens of thousands of people as the health system receives more doses of the vaccine.

Related reading: